NR 546: Final Comprehensive Exam
2026/2027 |Newly Released
Advanced Pharmacology for Psychiatric
Mental Health Nurse Practitioners
Chamberlain University
75 Questions with answers and detailled Rationale
Q1: Which neurotransmitter is primarily implicated in the pathophysiology of
schizophrenia due to its hyperactivity in the mesolimbic pathway?
A. Serotonin
B. Norepinephrine
C. Dopamine
D. GABA
Correct Answer: C
Rationale: Correct because the dopamine hypothesis of schizophrenia suggests that
hyperactivity of dopaminergic transmission in the mesolimbic pathway is associated
with positive symptoms such as hallucinations and delusions.
Q2: A patient is experiencing extrapyramidal symptoms (EPS) such as dystonia and
parkinsonism after starting an antipsychotic. Which pathway in the brain is primarily
affected by dopamine blockade leading to these motor side effects?
A. Mesocortical pathway
B. Nigrostriatal pathway
C. Tuberoinfundibular pathway
D. Mesolimbic pathway
,Correct Answer: B
Rationale: Correct because the nigrostriatal pathway regulates motor control;
blockade of D2 receptors in this pathway by antipsychotics leads to extrapyramidal
symptoms like dystonia and parkinsonism.
Q3: The antidepressant effect of SSRIs is believed to result from which neurobiological
change occurring over weeks of treatment?
A. Immediate increase in synaptic serotonin levels
B. Downregulation of postsynaptic serotonin receptors (5-HT1A)
C. Upregulation of norepinephrine reuptake pumps
D. Inhibition of monoamine oxidase enzyme
Correct Answer: B
Rationale: Correct because while synaptic serotonin increases immediately, the
therapeutic effect is delayed and correlates with the desensitization or downregulation
of postsynaptic autoreceptors, which normalizes neurotransmission.
Q4: Which receptor mechanism explains the antipsychotic efficacy of second-generation
antipsychotics with a lower risk of EPS compared to first-generation agents?
A. Tight binding to D2 receptors
B. Muscarinic M1 receptor antagonism
C. Serotonin 5-HT2A receptor antagonism coupled with D2 antagonism
D. Histamine H1 receptor agonism
Correct Answer: C
Rationale: Correct because 5-HT2A antagonism releases dopamine in the nigrostriatal
pathway, mitigating the risk of EPS while maintaining antipsychotic efficacy through D2
blockade in the mesolimbic pathway.
,Q5: A patient presents with a flat affect, avolition, and alogia. Negative symptoms of
schizophrenia are most closely associated with hypofunction in which brain pathway?
A. Mesocortical pathway
B. Mesolimbic pathway
C. Nigrostriatal pathway
D. Tuberoinfundibular pathway
Correct Answer: A
Rationale: Correct because hypodopaminergia in the mesocortical pathway, which
connects to the prefrontal cortex, is strongly associated with the negative symptoms and
cognitive deficits of schizophrenia.
Q6: Which amino acid serves as the primary precursor for the synthesis of serotonin?
A. Tyrosine
B. Tryptophan
C. Glutamate
D. Histidine
Correct Answer: B
Rationale: Correct because tryptophan is the essential amino acid precursor that is
hydroxylated and decarboxylated to form serotonin (5-hydroxytryptamine, 5-HT).
Q7: The mechanism of action of benzodiazepines involves enhancing the effect of GABA
at which receptor site?
A. GABA-A receptor
B. GABA-B receptor
C. NMDA receptor
D. 5-HT1A receptor
Correct Answer: A
Rationale: Correct because benzodiazepines bind to a specific site on the GABA-A
receptor complex, increasing the frequency of chloride channel opening in response to
GABA, resulting in neuronal inhibition.
, Q8: Long-term use of lithium is thought to alter which second messenger system that
may contribute to its mood-stabilizing effects?
A. Adenylyl cyclase / cAMP pathway
B. Phosphatidylinositol (PI) cycle
C. Tyrosine kinase pathway
D. Nitric oxide pathway
Correct Answer: B
Rationale: Correct because lithium inhibits the enzyme inositol monophosphatase,
leading to depletion of free inositol and modulation of the phosphatidylinositol second
messenger system.
Q9: Neurokinin 1 (NK1) receptor antagonism is a mechanism associated with the
therapeutic action of which class of psychiatric medications?
A. Antipsychotics
B. Antidepressants (specifically augmentation)
C. Mood stabilizers
D. Stimulants
Correct Answer: B
Rationale: Correct while this is a less common mechanism, neurokinin 1 receptor
antagonism (e.g., aprepitant) has been studied for depression; however, in standard
PMHNP curricula, Substance P and NK1 are often discussed in the context of novel
antidepressant targets or antiemetic effects. For this exam, the focus is on established
mechanisms.
2026/2027 |Newly Released
Advanced Pharmacology for Psychiatric
Mental Health Nurse Practitioners
Chamberlain University
75 Questions with answers and detailled Rationale
Q1: Which neurotransmitter is primarily implicated in the pathophysiology of
schizophrenia due to its hyperactivity in the mesolimbic pathway?
A. Serotonin
B. Norepinephrine
C. Dopamine
D. GABA
Correct Answer: C
Rationale: Correct because the dopamine hypothesis of schizophrenia suggests that
hyperactivity of dopaminergic transmission in the mesolimbic pathway is associated
with positive symptoms such as hallucinations and delusions.
Q2: A patient is experiencing extrapyramidal symptoms (EPS) such as dystonia and
parkinsonism after starting an antipsychotic. Which pathway in the brain is primarily
affected by dopamine blockade leading to these motor side effects?
A. Mesocortical pathway
B. Nigrostriatal pathway
C. Tuberoinfundibular pathway
D. Mesolimbic pathway
,Correct Answer: B
Rationale: Correct because the nigrostriatal pathway regulates motor control;
blockade of D2 receptors in this pathway by antipsychotics leads to extrapyramidal
symptoms like dystonia and parkinsonism.
Q3: The antidepressant effect of SSRIs is believed to result from which neurobiological
change occurring over weeks of treatment?
A. Immediate increase in synaptic serotonin levels
B. Downregulation of postsynaptic serotonin receptors (5-HT1A)
C. Upregulation of norepinephrine reuptake pumps
D. Inhibition of monoamine oxidase enzyme
Correct Answer: B
Rationale: Correct because while synaptic serotonin increases immediately, the
therapeutic effect is delayed and correlates with the desensitization or downregulation
of postsynaptic autoreceptors, which normalizes neurotransmission.
Q4: Which receptor mechanism explains the antipsychotic efficacy of second-generation
antipsychotics with a lower risk of EPS compared to first-generation agents?
A. Tight binding to D2 receptors
B. Muscarinic M1 receptor antagonism
C. Serotonin 5-HT2A receptor antagonism coupled with D2 antagonism
D. Histamine H1 receptor agonism
Correct Answer: C
Rationale: Correct because 5-HT2A antagonism releases dopamine in the nigrostriatal
pathway, mitigating the risk of EPS while maintaining antipsychotic efficacy through D2
blockade in the mesolimbic pathway.
,Q5: A patient presents with a flat affect, avolition, and alogia. Negative symptoms of
schizophrenia are most closely associated with hypofunction in which brain pathway?
A. Mesocortical pathway
B. Mesolimbic pathway
C. Nigrostriatal pathway
D. Tuberoinfundibular pathway
Correct Answer: A
Rationale: Correct because hypodopaminergia in the mesocortical pathway, which
connects to the prefrontal cortex, is strongly associated with the negative symptoms and
cognitive deficits of schizophrenia.
Q6: Which amino acid serves as the primary precursor for the synthesis of serotonin?
A. Tyrosine
B. Tryptophan
C. Glutamate
D. Histidine
Correct Answer: B
Rationale: Correct because tryptophan is the essential amino acid precursor that is
hydroxylated and decarboxylated to form serotonin (5-hydroxytryptamine, 5-HT).
Q7: The mechanism of action of benzodiazepines involves enhancing the effect of GABA
at which receptor site?
A. GABA-A receptor
B. GABA-B receptor
C. NMDA receptor
D. 5-HT1A receptor
Correct Answer: A
Rationale: Correct because benzodiazepines bind to a specific site on the GABA-A
receptor complex, increasing the frequency of chloride channel opening in response to
GABA, resulting in neuronal inhibition.
, Q8: Long-term use of lithium is thought to alter which second messenger system that
may contribute to its mood-stabilizing effects?
A. Adenylyl cyclase / cAMP pathway
B. Phosphatidylinositol (PI) cycle
C. Tyrosine kinase pathway
D. Nitric oxide pathway
Correct Answer: B
Rationale: Correct because lithium inhibits the enzyme inositol monophosphatase,
leading to depletion of free inositol and modulation of the phosphatidylinositol second
messenger system.
Q9: Neurokinin 1 (NK1) receptor antagonism is a mechanism associated with the
therapeutic action of which class of psychiatric medications?
A. Antipsychotics
B. Antidepressants (specifically augmentation)
C. Mood stabilizers
D. Stimulants
Correct Answer: B
Rationale: Correct while this is a less common mechanism, neurokinin 1 receptor
antagonism (e.g., aprepitant) has been studied for depression; however, in standard
PMHNP curricula, Substance P and NK1 are often discussed in the context of novel
antidepressant targets or antiemetic effects. For this exam, the focus is on established
mechanisms.
